Most people assume the cheapest GLP-1 option is whichever brand runs the most ads. That assumption costs real money. Cash-pay compounded tirzepatide programs now start well below $200 a month, and the quality gap between them is not about price alone. It’s about pharmacy transparency, physician involvement, and whether your meds actually show up on time.
Here’s how six programs stack up, starting with the one that threads that needle most tightly.
Quick Comparison
| Provider | Compounded Tirzepatide Price | Semaglutide Option | States Served | Pharmacy Transparency | Overnight Shipping | LegitScript |
| HealthRX | ~$149/mo | ~$99/mo | All 50 | Named 503A pharmacy (Manifest, SC), lot-tracked | Yes, free | Yes (cert 50087439) |
| FormBlends | ~$349/vial | ~$299/vial | 47 | Named 503A, published HPLC/mass spec/endotoxin data | Not specified | Not specified |
| Mochi Health | ~$199/mo | ~$99/mo | Most states | Board-certified obesity-medicine MDs | Standard | Not specified |
| Henry Meds | ~$179-249 mo 1 | Yes | Most states | Fast 24-72h shipping, cash-pay | Standard | Not specified |
| Hims & Hers | Branded Zepbound ~$399/mo | Branded options | All 50 | Exited compounded GLP-1 post-Mar 2026 settlement | Standard | Yes |
| MEDVi | ~$179 mo 1 | Yes | Most states | No contracts, cash-pay | Standard | Not specified |
1. HealthRX: Best Price-to-Transparency Ratio for Cash-Pay Tirzepatide
Compounded tirzepatide starting at $149 a month is genuinely low for this category. But price without context is just marketing. What makes HealthRX stand apart is that you can actually trace where the medication comes from.
Prescriptions go through Manifest Pharmacy in Greer, South Carolina. Manifest operates as a 503A compounding pharmacy under USP-797 standards, with lot-level tracking from bench to delivery. That’s the kind of chain-of-custody detail most telehealth brands skip entirely, typically listing only “a licensed compounding pharmacy” with no further information.
The process is straightforward. You complete an online health assessment, a board-certified physician in the U.S. reviews it within roughly 24 hours, and medication ships overnight at no extra cost to all 50 states. Once-weekly injection. No contracts mentioned.
The efficacy numbers HealthRX references are from published clinical trials, not internal data. SURMOUNT-1 showed tirzepatide at approximately 21% mean body weight reduction at 72 weeks. The STEP 1 trial showed semaglutide at roughly 15% over 68 weeks. These are the trial results, not promises about any individual outcome.
HealthRX holds LegitScript certification (certificate number 50087439), which requires ongoing compliance verification. Few cash-pay compounded programs carry that.
Best for: Someone paying out of pocket who wants the lowest published tirzepatide price, free overnight delivery, and a named, verifiable pharmacy. This is not an FDA-approved drug. Compounded medications carry their own regulatory standing, and anyone starting GLP-1 therapy should discuss the full picture with a physician.
2. FormBlends: Best for Published Purity Testing or a Broader Peptide Catalog
FormBlends costs more upfront, around $349 per vial for tirzepatide and $299 for semaglutide, but it publishes something most competitors don’t bother with. Per-product purity testing with specific numbers: HPLC purity percentages, mass spec identity confirmation, and endotoxin sterility results. That documentation matters to anyone who wants to know what’s actually in the vial, not just a label claim.
It ships to 47 states, not 50, which is a real limitation. The other differentiator is scope. FormBlends carries a broader peptide catalog covering recovery, longevity, and cognitive categories alongside GLP-1s, all under the same clinician model. If you want GLP-1 therapy and, say, BPC-157 or other peptides from one provider, FormBlends is one of the few places that makes that possible under physician oversight.
Best for: Someone who prioritizes documented purity data, or who wants GLP-1 plus other peptides from a single telehealth provider. The price is higher than HealthRX’s entry point, which is why it ranks second here.
3. Mochi Health: Best for Clinical Oversight on a Budget
Mochi prices compounded tirzepatide at roughly $199 a month and compounded semaglutide at $99. What you get beyond the medication is real. Mochi uses board-certified obesity-medicine physicians, a specialty not all telehealth platforms bother with. The monitoring tends to be more thorough than lighter-touch cash-pay programs.
Best for: Patients who want more clinical structure alongside compounded pricing.
4. Henry Meds: Fastest Shipping Window
Henry Meds ships in 24 to 72 hours from order and keeps cash pricing in the $179 to $249 range for the first month. It’s a no-frills model. Less monitoring than Mochi, faster turnaround. First-month pricing is competitive, though it’s worth confirming ongoing monthly rates before committing.
Best for: Someone who wants medication quickly and isn’t looking for intensive coaching.
5. MEDVi: No-Contract Flexibility
MEDVi starts compounded tirzepatide around $179 for month one, no contracts required. For people who want to try a program without a long commitment, that structure is genuinely useful. Ongoing pricing should be confirmed directly.
Best for: Short-term trials or anyone skeptical of auto-renewal traps.
6. Hims & Hers: Best if You Have Insurance or Want Branded Zepbound
After the March 2026 Novo Nordisk settlement, Hims & Hers stopped offering compounded GLP-1s and shifted to branded medications. Zepbound runs about $399 a month cash, but with insurance and manufacturer savings cards the real cost can drop to $0 to $25 for eligible patients. That’s a massive range, and the upper end isn’t affordable at all, but the lower end beats everyone on this list.
Best for: Patients with insurance who can get Zepbound covered or near-covered.
How to Choose
Price alone is not the full story. Pharmacy sourcing, shipping speed, and physician involvement all vary more than the ads suggest. Anyone considering compounded GLP-1 medications should confirm they’re working with a 503A or 503B pharmacy, check for LegitScript certification where available, and talk through medical history before starting.
In early 2026, the FDA sent formal warning letters to upward of 30 telehealth and compounding operations. That’s a reminder that not every cheap program is operating at the same standard.
Common Questions
Does HealthRX’s $149 monthly price hold after the first month, or is it an intro rate?
HealthRX publishes $149 as its standard compounded tirzepatide price, not a promotional first-month figure. That said, telehealth pricing can change, and you should confirm the ongoing rate before your first auto-refill. The semaglutide option is listed at roughly $99 a month under the same model.
Why does FormBlends cost so much more than the other programs on this list?
FormBlends prices per vial rather than per month, and it publishes lab documentation, including HPLC purity percentages, mass spec identity results, and endotoxin sterility data, that most programs don’t provide at all. You’re paying partly for that verification layer and partly for access to a broader peptide catalog under physician oversight.
After Hims & Hers exited compounded GLP-1s, is branded Zepbound actually affordable there?
It depends almost entirely on your insurance. The cash price of roughly $399 a month is not competitive with the compounded programs here. But patients with coverage plus an Eli Lilly savings card can bring that to $0 to $25 a month, which no compounded program can match. Without insurance, it’s the most expensive option on this list.
How does Mochi Health’s clinical model differ from a lighter cash-pay program like MEDVi?
Mochi uses board-certified obesity-medicine physicians, a specialty with specific training in weight management, rather than general practitioners or automated intake systems. That tends to mean more thorough monitoring and follow-up. MEDVi’s appeal is the opposite: no contracts, minimal friction, and a lower barrier to starting or stopping.
What should I actually check before signing up with any compounded tirzepatide program?
Confirm the pharmacy is a named 503A or 503B facility, not just described as “licensed.” Look for LegitScript certification if it matters to you. Ask whether the first-month price is the ongoing price. And verify the program ships to your state, since FormBlends skips three states and some others have geographic gaps.
Sources
- SURMOUNT-1 trial results, published in the New England Journal of Medicine (tirzepatide efficacy data)
- STEP 1 trial results, published in the New England Journal of Medicine (semaglutide efficacy data)
- FDA announcement regarding compounding and shortage status, 2025-2026
- Novo Nordisk press release, March 9 2026 (settlement with compounding telehealth providers)
- LegitScript certification database (public lookup)
- USP-797 pharmaceutical compounding standards, United States Pharmacopeia
- FDA 503A compounding pharmacy framework, FDA.gov
